Alemtuzumab/dexamethasone/fludarabine: Mycoses, hepatitis B, tuberculosis and parasitic infections: 51 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1421, 2012-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alemtuzumab: First report of hepatitis B virus reactivation: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1037, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Alemtuzumab/fludarabine: EBV-associated B-cell lymphoma in patients with peripheral T-cell lymphoma: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Alemtuzumab/cyclophosphamide/fludarabine: EBV-induced B cell lymphoma in elderly patients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1170, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Fludarabine/rituximab/alemtuzumab: Progressive multifocal leukoencephalopathy: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Fludarabine/rituximab: Reactivation of hepatitis B: case report

By  

Reactions Weekly, Vol. 1, Iss. 1168, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite